NCT00298883View on ClinicalTrials.gov

Desensitization of Renal Transplant Candidates

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

August 31, 2008

Study Completion Date

December 31, 2008

Conditions
End Stage Renal DiseaseKidney Transplantation
Interventions
DRUG

Myfortic

Myfortic 360mg PO BID for six weeks

Trial Locations (1)

32610

University of Florida, Gainesville

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

University of Florida

OTHER